UBS Bets on Target's $2B Turnaround Plan for 2026 Outlook
UBS analysts view Target's planned $2 billion investment for 2026 as a bold, two-pronged turnaround bet. The plan spl...
This brief explains the asset selection logic behind equal weighted indices and how different asset classes impact portfolio balance.
23,793 articlesUBS analysts view Target's planned $2 billion investment for 2026 as a bold, two-pronged turnaround bet. The plan spl...
The Trade Desk once looked like a safe-growth engine in digital advertising. As growth slows and the landscape shifts...
Investors want a clear compass for Alphabet stock in the next five years. This article breaks down the growth drivers...
Investors keep asking if Vertex Pharmaceuticals is headed to $600. This article breaks down the core business, pipeli...
In 2026, corporate bond spreads tightening is reshaping risk and return for the iShares LQD ETF, as yields, credit qu...
NVIDIA and Palantir are teaming up to push AI into the most secure government environments. This article breaks down ...
Volatility in tech stocks has investors watching Micron Technology (MU) closely. This guide breaks down why MU could ...
Crispr Therapeutics Stock Absurdly Cheap signals a rare biotech bargain. Learn what could drive a 437% upside, the ca...
A high-profile insider sale at CoreWeave has sparked questions about the company’s trajectory. This guide explains wh...
Oil has moved markets again, with crude flirting with triple digits and energy stocks lighting up in response. This g...
Super Micro Computer stunned investors with a colossal AI server backlog, but a planned $7 billion capital raise trig...
An executive’s $3.6 million share sale can spark questions for investors. This comprehensive guide explains what the ...